Trials / Conditions / Stage IVA Nasopharyngeal Carcinoma
Stage IVA Nasopharyngeal Carcinoma
3 registered clinical trials studyying Stage IVA Nasopharyngeal Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive NCT04231864 | Alain Algazi | Phase 2 |
| Terminated | Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nas NCT03049358 | Stanford University | N/A |
| Active Not Recruiting | Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA NCT02135042 | NRG Oncology | Phase 2 / Phase 3 |